Candel Therapeutics, Inc. (CADL)
11.58
-0.58
(-4.81%)
USD |
NASDAQ |
Sep 10, 12:27
Candel Therapeutics 1 Year Total Returns (Daily) : 144.9% for Sept. 9, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 09, 2026 | 144.9% |
| September 08, 2026 | 147.1% |
| September 04, 2026 | 161.1% |
| September 03, 2026 | 154.1% |
| September 02, 2026 | 125.3% |
| September 01, 2026 | 121.9% |
| August 31, 2026 | 125.7% |
| August 28, 2026 | 124.6% |
| August 27, 2026 | 132.7% |
| August 26, 2026 | 122.8% |
| August 25, 2026 | 138.2% |
| August 24, 2026 | 116.1% |
| August 21, 2026 | 126.8% |
| August 20, 2026 | 122.1% |
| August 19, 2026 | 142.8% |
| August 18, 2026 | 102.2% |
| August 17, 2026 | 99.67% |
| August 14, 2026 | 94.04% |
| August 13, 2026 | 84.38% |
| August 12, 2026 | 68.19% |
| August 11, 2026 | 71.50% |
| August 10, 2026 | 74.42% |
| August 07, 2026 | 81.34% |
| August 06, 2026 | 77.52% |
| August 05, 2026 | 69.53% |
| Date | Value |
|---|---|
| August 04, 2026 | 66.56% |
| August 03, 2026 | 60.10% |
| July 31, 2026 | 55.31% |
| July 30, 2026 | 50.23% |
| July 29, 2026 | 43.07% |
| July 28, 2026 | 41.11% |
| July 27, 2026 | 41.88% |
| July 24, 2026 | 36.57% |
| July 23, 2026 | 41.67% |
| July 22, 2026 | 51.27% |
| July 21, 2026 | 55.56% |
| July 20, 2026 | 41.99% |
| July 17, 2026 | 47.11% |
| July 16, 2026 | 38.39% |
| July 15, 2026 | 54.24% |
| July 14, 2026 | 53.50% |
| July 13, 2026 | 65.92% |
| July 10, 2026 | 54.31% |
| July 09, 2026 | 62.40% |
| July 08, 2026 | 88.55% |
| July 07, 2026 | 97.39% |
| July 06, 2026 | 96.67% |
| July 02, 2026 | 96.99% |
| July 01, 2026 | 103.7% |
| June 30, 2026 | 103.6% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 11.43% |
| Alnylam Pharmaceuticals, Inc. | -46.49% |
| Anika Therapeutics, Inc. | 139.2% |
| Savara, Inc. | 41.75% |
| Vericel Corp. | 19.82% |